Jana Medical trading suspended over delayed financial disclosure

02/09/2025 Argaam
Logo ofJana Medical Co.

Logo of Jana Medical Co.

The Saudi Exchange (Tadawul) placed a one-session trading halt on shares of Jana Medical Co. on Sept. 2.

 

The suspension followed Jana’s failure to disclose its financial statements for the period ending June 30, 2025, within the deadline set by the Rules on the Offer of Securities and Continuing Obligations.

 

For more news on listed companies

 

The suspension is in accordance with the Exchange’s authority under the Listing Rules and the Procedures for Suspending the Trading of Listed Securities.

 

Trading in Jana’s shares is set to resume on Sept. 3 for 20 trading sessions. The company is required to publish its financial results by Oct. 1.

 

If Jana fails to release the financial statements by the Oct. 1 deadline, Tadawul will impose another trading halt starting Oct. 2, which will remain in place until the disclosure is made.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.